Objectives: 1. To determine if resting energy expenditure (REE) adjusted for body composition is elevated in HIV-positive males when compared with healthy controls in the era of highly active antiretroviral therapy. 2. To examine the accuracy of prediction equations for estimating REE in people with HIV. 3. To determine if REE adjusting for body composition is significantly different between those HIV-positive subjects reporting lipodystrophy (LD) or weight loss (!5%) and those who are weight stable when compared to controls. Design: Cross-sectional study. Setting: Tertiary referral hospital HIV unit and an outpatient clinic specializing in HIV care. Subjects: HIV-positive males (n ¼ 70) and healthy male controls (n ¼ 16). Methods: REE was measured using indirect calorimetry. Body composition was assessed using bioelectrical impedance analysis. Results: 1. REE when adjusted for fat-free mass and fat mass using the general linear model (analysis of covariance) was greater in HIV-positive subjects than controls (7258 AE 810 kJ, n ¼ 70 vs 6615 AE 695 kJ, n ¼ 16, P < 0.05). 2. The Harris and Benedict, Schofield, Cunningham and the two equations previously published by Melchior and colleagues in HIV-positive subjects all gave an estimate of REE significantly different from the measured REE in the HIV-positive subjects, therefore a new prediction equation was developed. The inability of the published equations to predict REE in the different HIV-positive subgroups reflected the heterogeneity in body composition. 3. REE adjusted for fat-free and fat mass was significantly greater in the both the HIV patients who were weight stable and those with lipodystrophy compared with the healthy controls. Conclusion: REE is significantly higher in HIV-positive males when compared with healthy controls. Body composition abnormalities common in HIV render the use of standard prediction equations for estimating REE invalid. When measuring REE in HIV-positive males adjustment steps should include fat-free and fat mass.
Introduction
Several authors have reported that, compared with healthy controls, HIV-infected patients have increased resting energy expenditure (REE), even in the absence of acute secondary infection or malignancy (Hommes et al, 1990 (Hommes et al, , 1991 Macallan et al, 1995; Melchior et al, 1991; Grunfeld et al, 1992; Poizot-Martin et al, 1994; Schwenk et al, 1996; Sharpstone et al, 1996a,b; Heijligenberg et al, 1997) . In contrast Kotler et al (1990) found that REE was decreased in HIV-positive subjects when compared with controls and Suttman et al (1993) showed no difference in REE between HIV-positive subjects and controls.
Some of the inconsistencies may be related to methodological differences in accounting for the effects of body composition abnormalities on the interpretation of the results of REE measurements. The fat-free mass (FFM) contains most of the body's metabolically active, oxygenrequiring tissues and is reported to explain 70 -80% of the variability in the REE (Cunningham, 1991) . Body fat, although less metabolically active than the FFM, has also been shown to be an independent predictor of REE in some studies (Ferraro & Ravussin, 1992) . Therefore in disease states where abnormalities of body composition are common, prediction equations based on healthy populations are subject to inaccuracy.
The inconsistency in the literature makes estimating energy requirements for people with HIV=AIDS problematic in clinical practice. It is also unclear what influence highly active antiretroviral therapy and the consequential immunological improvements in patients receiving this therapy has on REE in people with HIV=AIDS.
The aims of this study were to examine the accuracy of prediction equations based on height, weight and age and those based on fat-free mass for assessing REE and to determine their utility in men with HIV=AIDS in the era of highly active antiretroviral therapy. Highly active antiretroviral therapy (HAART) has been associated with a syndrome of body composition abnormalities, referred to as lipodystrophy syndrome (LD). This syndrome is characterized by peripheral subcutaneous fat wasting and=or visceral adiposity often accompanied by serum lipid abnormalities and insulin resistance (Carr et al, 1998) . A secondary aim of this study was to determine if REE calculated to account for body composition is significantly different in those reporting lipodystrophy. We also wished to determine if REE was affected by weight loss in this patient group. It was planned that if the existing equations proved inadequate for determining energy expenditure in our sample population a new equation would be developed. In addition we wished to examine any correlations between REE and the markers of disease progression which we had measured.
Methods

Subjects
Male HIV-positive subjects were recruited from the Royal Prince Alfred Hospital HIV=AIDS service and the Albion Street Centre, an ambulatory care facility for people with HIV=AIDS. The subjects were participating in HIV-related nutrition studies at these centres (only baseline measures were used) and all subjects signed written informed consent. The studies were approved by the Central Sydney Area Health Service Research Ethics Committee and the South Eastern Sydney Area Health Service Research Ethics Committee. For comparison a convenience sample of healthy male control subjects with similar age and weight to the initial HIV subjects was recruited from the staff at the centres.
Weight and height were measured with subjects in their underclothes and fat-free mass was estimated using bioelectrical impedance analysis. Resistance and reactance were measured using a BIM 4 bioelectrical impedance analyser (SEAC, Uniquest, St Lucia, Australia) and fat-free mass was estimated using the equation of Lukaski and Bolonchuk (1987) . This equation has been shown previously to be accurate in HIV-positive subjects when compared with dual energy X-ray absorptiometry (Shevitz et al, 1999) . Fat mass was calculated by arithmetic deduction from body weight and expressed as a percentage thereof.
Dietary intake and activity levels were estimated to examine their role as potential confounders in the relationship between REE and FFM between the HIV-positive groups. Dietary intake was assessed using a 3-day estimated food record. Subjects were asked to record the weight and describe the contents of all items consumed (food and fluid for 3 days). When weights of food=fluid were not available subjects were asked to estimate the portion size using diagrams of standardized food portions provided with the food record, or by using household measures. The method of completing the food diary was explained thoroughly to each subject and checked for accurate recording by an Accredited Practising Dietitian (MB or JMJ), and energy intake was obtained by entering the information obtained from the dietary records into the Foodworks V 2.0 software package (Xyris software, Brisbane, Australia) which uses the Australian national food database Nutritional Data Table (NUTTAB) . Activity levels were assessed using a 3 day exercise diary where subjects were asked to document periods of physical activity (eg walking, gardening, weight training). Activity levels were then estimated on a scale of 1 -5 to match the descriptions provided with the Harris & Benedict equation (Department of Nutrition, Dietetics and Food Sciences, 1996) .
Resting energy expenditure was measured by indirect calorimetry using a DeltaTrac II Metabolic Monitor (Datex, Helsinki, Finland) . Indirect calorimetry measures respiratory gas exchange (oxygen consumption and carbon dioxide production). Respiratory gas exchange measurement allows calculation of the energy expenditure associated with the oxidation of the energy-producing fuels, carbohydrate, fat, protein and alcohol.
The oxygen consumption and carbon dioxide production were calculated from equations (Datex Corporation, 1995) , based on the Haldane transformation. The oxygen consumption and carbon dioxide production were then used to calculate resting metabolic rate (Datex Corporation, 1995) based on the Weir equation (Weir, 1949) . A standard value of 12 g nitrogen=24 h was used for urinary nitrogen excretion (Bursztein et al, 1989) .
All measures except the dietary intake and activity level assessment were conducted on the same day after a 12 h overnight fast. Subjects were asked not to smoke or exercise on the morning of the assessment and not to consume alcohol for at least 24 h prior to the assessment. REE was measured for 30 min; the first 5 min were discarded to Energy requirements for HIV/AIDS men MJ Batterham et al allow for adjustment to the equipment. The dietary and activity measures were retrieved within a month of the assessment. The prediction equations used for comparison were those published by Harris and Benedict (1919; HBE) , which uses weight, height and age as the prediction variables in a sexspecific equation, Schofield (1985; SE) , which uses weight and age as the prediction variables in a sex-specific equation, and Cunningham (1991; CE) , which uses FFM as the prediction variable. These equations (HBE, SE and CE) were all developed in healthy subjects. Two other equations published by Melchior et al (1991 Melchior et al ( , 1993 ME91, ME93) , both of which use FFM as the prediction variable, were developed in asymptomatic HIV-positive patients prior to the introduction of HAART and are also used for comparison in this study. The equations used are shown in Table 1 .
Data analysis
Data were analysed using SPSS for Windows (Version 10.0.5; , SPSS Inc., Chicago, IL, USA) and STATA (Version 6, 02 August 1999, STATA Corporation, College Station, TX, USA). Variables between groups were compared using independent samples t-tests. Analysis of variance (ANOVA) was used when there were more than two groups for comparison with post hoc analysis using Tukey's test. Multiple linear regression was used to determine the relationship between variables and to develop the prediction equations. The variables of interest (REE, fat-free mass and fat mass) were included in the model as well as potential confounding variables. Age (Das et al, 2001) , intake (Newsholme & Leech, 1988 ), smoking (current or non-smoker; Dallosso & James, 1984) and activity levels (Wadden et al, 1997 ) may all affect REE, therefore these variables were added as covariates in the regression model. Because of the relationships between circulating plasma HIV RNA viral load and CD4 Tcell count and REE (Mulligan et al, 1997; Shevitz et al, 1999) , and WHR and REE (Kosmiski et al, 2001) , viral load, CD4 Tcell numbers and WHR were also included in the model. The all-variables-entered model was checked for adequacy by examining the residual plots, leverage and Cook's distance, and multicollinearity was excluded by examining the correlation coefficients between the continuous variables and calculating the variance inflation factors (Kleinbaum et al, 1988) . A forward stepwise regression analysis was used to determine the best model for the prediction equation. A bootstrap resampling procedure was used to calculate the true prediction error of the best model (Efron & Tibshirani, 1993) . In lieu of a second sample in which to cross-validate the new prediction equation, 100 bootstrap samples with replacement were generated from the original data set and the optimism was calculated. The optimism is the amount by which the average residual mean squared error (MSE) underestimates the true mean squared error. The optimism is added to the residual MSE generated by the prediction equation. A small difference between the two SEEs (square root of the residual mean squared error) is an indication that comparable SEEs would be obtained in a similar set of subjects.
The bias was determined and paired t-tests were used to ascertain if the differences between measured REE and the predicted value were significant (Bland & Altman, 1986) for the REE prediction equations. Analysis of covariance (ANCOVA) was used to determine if dietary intake was significantly different between the three HIV-positive groups when age, weight, height and activity level were added as covariates.
In order to allow for comparison of the HIV-positive and control groups while avoiding mathematical artefacts associated with non-zero intercepts when REE is divided by FFM (Ravussin & Bogardus, 1989) , the general linear model procedure in SPSS was used to estimate adjusted means in a univariate analysis of covariance (ANCOVA); interaction terms were initially included in the analysis to evaluate the homogeneity-of-slopes assumption (Green et al, 2000) . For comparison with previous literature the data are also presented as REE per kg of FFM where the negative x intercept when y ¼ 0 of the regression (11.9 kg) has been added to the denominator before the division (Macallan et al, 1995; Ravussin & Bogardus, 1989) . Fat mass was also adjusted for by using ANCOVA, post hoc analysis of main effects was conducted with a Bonferroni adjustment for multiple comparisons.
Results
Seventy clinically stable HIV-positive males and 16 healthy male controls participated in the study. The subject characteristics are outlined in Table 2 . The mean age, weight, height, body mass index, fat-free mass and percentage body fat mass were not significantly different between the HIV-positive subjects and the controls. Sixty-two of the HIVpositive subjects were taking antiretroviral therapy, and seven were antiretroviral naive; one was having a planned treatment interruption and currently not using HAART. Subjects were divided into three groups a priori: (1) clinically documented unintentional ongoing weight loss of !5% of usual body weight within the last 6 months without evidence of lipoatrophy; (2) those with lipodystrophy who were weight stable (AE5% usual weight); (3) those without (1991) 1366 þ 126 Â FFM Melchior et al (1993) 1379 þ 123 Â FFM W, weight in kg: H, height in cm: A, age in years: FFM, fat-free mass in kg.
Energy requirements for HIV/AIDS men MJ Batterham et al lipodystrophy who were weight stable (AE5% usual weight). Seventeen HIV positive subjects had experienced documented weight loss (mean 7.17 AE 3.61 kg). Thirty of the HIVpositive subjects reported lipodystrophy, which was defined as peripheral subcutaneous fat wasting and=or visceral adiposity and confirmed by clinical examination. Self-report of lipodystrophy was supported by a higher waist-to-hip ratio (0.95 AE 0.07 vs 0.89 AE 0.13, P ¼ 0.03) in those reporting lipodystrophy. In addition fasting serum measures were available for those reporting lipodystrophy (n ¼ 30) and those who were weight stable (n ¼ 23). Fasting cholesterol (5.9 AE 1 vs 5.5 AE 1.1 mmol=l, P ¼ 0.012) and triglycerides (4.0 AE 6.3 vs 1.8 AE 1.0 mmol=l, P ¼ 0.047) were significantly higher in those reporting lipodystrophy. All subjects reporting LD had previously taken or were currently taking a protease inhibitor for >6 months. Of those reporting lipodystrophy 11 reported lipoatrophy alone, four reported visceral adiposity alone and 15 reported both lipoatrophy and visceral adiposity. The remaining 23 subjects were body contour (self-report) and weight stable (with a change of <5% weight in the last 6 months). Differences in activity level (P ¼ 0.132 w 2 ) and the proportion of patients using HAART (P ¼ 0.379 w 2 ) were not significantly different between the three groups.
Differences between the three groups of HIV-positive subjects (lipodystrophy, weight stable and weight loss) compared with controls are outlined in Table 3 . Measured REE was not significantly different between the group of HIVpositive and control subjects (P ¼ 0.299), however within the HIV-positive subjects those with weight loss had a significantly lower measured absolute REE than the weight stable and LD groups.
Importantly, all of the prediction equations used gave an estimated value for REE which was significantly different from the measured value for the HIV-positive subjects (HBE bias 7519 AE 828 kJ, P < 0.001, SE bias 7305 AE 870 kJ P ¼ 0.005; CE bias 7807 AE 828 kJ, P < 0.001; M91 bias þ925 AE 820 kJ, P < 0.001; M93 bias þ774 AE 816 kJ, P < 0.001). Both the Schofield (bias þ310 AE 745 kJ, P ¼ 0.119) and the Cunningham (bias 7213 AE 720 kJ, P ¼ 0.257) equations produced an estimate of REE in the control group with a non-significant bias; however, the bias for REE estimated using the HBE was statistically significant in the control subjects (bias þ360 AE 653 kJ, P ¼ 0.044). When the absolute REE was expressed as a ratio to the predicted REE estimated using the HBE, SE and CE, the HIV-positive subjects had significantly higher observed: predicted REE (P < 0.001 HBE, P ¼ 0.014 SE, P ¼ 0.006 CE see Table 3 ).
Using analysis of variance with post-hoc analysis (Tukey's test) we compared predicted vs measured energy expenditure in the four groups to determine if any of the subgroups of HIV-positive subjects were hypermetabolic compared with the control group and the other HIV-positive sub-groups. The weight stable and LD HIV-positive groups were hypermetabolic compared with the weight-losing HIV-positive group and controls. This was found with the weight-, height-and sex-based prediction equations (HBE, SE). In the FFM-based equation (CE) the only significant difference was between the weight stable group and the control group (P ¼ 0.008). When REE was expressed as a percentage of predicted REE using the two HIV-specific equations (ME91, ME93), there was no significant difference between the three HIV-positive groups. When REE was expressed per kg FFM the difference between HIV positive and controls was significant (P ¼ 0.001 absolute, P ¼ 0.004 adjusted). Using ANCOVA the adjusted REE in the weight stable group was significantly higher than in the control group (P ¼ 0.010). When fat mass was included in the analysis of covariance along with the fat free mass both the weight stable (P ¼ 0.001) and LD (P ¼ 0.002) groups were significantly higher than the controls. No statistically significant differences existed within the HIV-positive subjects when the Energy requirements for HIV/AIDS men MJ Batterham et al lipodystrophy subdivisions were included (that is weight stable, weight loss, lipoatrophy, visceral adiposity and mixed syndrome, P > 0.05). Correlation coefficients for age, viral load, CD4 T-cell count, WHR, FFM and FM with REE were calculated for the HIV-positive subjects. Absolute REE correlated with FFM (r ¼ 0.750, P < 0.001) and FM (r ¼ 0.425, P < 0.001), but not with percentage fat mass (r ¼ 0.0932, P ¼ 0.443). REE per kg FFM correlated with VL (r ¼ 0.2462, P ¼ 0.05), REE adjusted for FFM tended to correlate with VL (r ¼ 0.239, P ¼ 0.060), the significance decreased when the partial correlation accounted for both fat-free and fat mass (r ¼ 0.206, P ¼ 0.107). REE (absolute or adjusted for FFM and FM) did not correlate with age or CD4 count. REE tended to correlate with WHR (r ¼ 0.236, P ¼ 0.049). When these linear variables were entered into a regression model, with REE as the dependent variable and FFM, FM, age, intake, smoking, exercise, WHR, viral load and CD4 T-cell count as the independent variables, only FFM (P < 0.001) and FM (P ¼ 0.001) were significantly associated with REE. We chose to use fat mass (kg) rather than percentage fat mass in this model as the univariate correlation for REE and percentage fat mass was not significant. Correlations between the continuous independent variables were significant for age and intake (r ¼ 70.364, P ¼ 0.004), intake and fat-free mass (r ¼ 0.2586, P ¼ 0.046), viral load and CD4 counts (r ¼ 70.428, P ¼ 0.001). The variance inflation factors were between 1.02 and 1.12, mean 1.06. As the individual and mean values are less than 10, multicollinearity does not invalidate this model (Kleinbaum et al, 1988) . There was no NS, predicted value not significantly different from measured value using paired t-test, for all other groups the predicted value was significantly different from the measured value using paired t-tests (P > 0.05; Bland & Altman, 1986 ). *HIV-positive group significantly different from control group (P < 0.05) using independent sample t-test.
{ Assessed using analysis of covariance for all subjects combined. Presented both as the value adjusted for FFM in kJ and by adding the value of y at the x intercept (11.90 kg) in order to adjust for the non-zero intercepts (Ravussin & Bogardus, 1989 ) and the value adjusted using ANCOVA. 
Discussion
The main findings of this study were that the existing published prediction equations for estimating energy expenditure were not accurate for estimating REE in HIV-positive men in the HAART era. While both the Schofield and Cunningham equations were able to estimate REE with a non-significant bias in the study's healthy controls, these equations produced a significant bias in the estimate of REE in the HIV-positive subjects of this study. The equations developed in HIV-positive subjects prior to the HAART era also produced inaccurate estimates of REE in this sample of HIV-positive subjects. A new equation was produced to estimate REE in HIV-positive subjects.
This study provided data relevant to the secondary aim of this study of determining if REE accounting for body composition is significantly different in those reporting lipodystrophy. Previously Renard et al (1999) demonstrated that absolute REE was higher in HIV-positive subjects with LD compared with HIV-positive controls, although the difference was not statistically significant. However they did show that the discrepancy between the measured REE and the REE predicted using the Harris Benedict equation was significant in the group with lipodystrophy (þ19.7 AE 11.6%, n ¼ 28) whereas the difference in the HIV-positive control group (þ11.2 AE 11.6%, n ¼ 12) was not significant. Although FFM was measured in this study and strong correlations demonstrated between REE and FFM in both subjects with and without LD, comparisons of REE between groups accounting for FFM were not made in this study. Kosmiski et al (2001) compared REE=kg FFM in patients with lipodystrophy (12=14 with mixed syndrome) on protease inhibitors with HIV-positive patients without lipodystrophy on protease inhibitors and a third group of HIV-positive subjects who were PI-naive. Their results suggested REE=kg FFM was elevated in the lipodystrophy group when compared with the other two groups. Our results show that REE adjusted for body composition is not elevated in HIV-positive subjects with lipodystrophy (when the groups were pooled) when compared with HIV-positive subjects without the syndrome. The lack of a formal definition of lipodystrophy and differences in the recruitment criteria and body composition methodology may explain the differences in the results between our study and that of Kosmiski and colleagues; our group also had a larger percentage of subjects reporting lipoatrophy alone, which may have influenced our findings.
Few other studies have investigated REE in HIV-positive subjects since the introduction of HAART. Shevitz et al (1999) investigated the relationship between HAART use, HIV viral load and REE in 372 HIV-positive patients and found that HIV viral load and HAART use had independent effects on REE in HIV-positive subjects and that the pathway by which HAART impacted on REE was independent of that on viral burden. Shevitz et al (1999) did not compare their results with healthy controls and were not investigating the effects of weight loss or LD on REE in HIV-positive subjects. These authors do report that mean REE was 16% higher than REE calculated using the HBE however the elevation was not significant because of a large SD (12%). We were unable to reliably establish the independent effect of HAART use in the present study as only eight of the HIV-positive subjects were not taking HAART therapy.
In this study the relationship between viral load and REE was of borderline significance when REE was expressed per kg of FFM and the strength of the relationship decreased when there was a control step for FFM using ANCOVA and further when FM was similarly adjusted for. Previously Mulligan et al (1997) reported a significant relationship between viral load and REE per kg of FFM, Shevitz et al (1999) found the relationship between viral load and REE was significant only when FFM, age and HAART use were controlled for in the analysis. Further investigation in longitudinal study is required to resolve the relationship between REE and viral load at different stages of viral control and rebound.
A limitation of the present study is the use of bioelectrical impedance analysis to assess body composition. Although some studies have shown assessment of body composition is accurate in HIV-positive subjects using the Lukaski and Bolunchuk equation used in the present study (Shevitz et al, 1999) when compared with DEXA scanning, others in pre-HAART studies have found the results obtained using this equation to have a significant bias when similarly compared with DEXA scanning (Corcoran et al, 2000) . The use of different body composition techniques may also have caused some of the inconsistencies in the previous literature. Although many previous studies discussed in this paper used field methods of body composition assessment (bioelectrical impedance analysis or anthropometry; Hommes et al, 1990 Hommes et al, , 1991 Melchior et al, 1991 Melchior et al, , 1993 Shevitz et al, 1999) to examine the relationship between REE and body composition, the prediction equations used in these studies were not identical. The validity of bioelectrical impedance for accuEnergy requirements for HIV/AIDS men MJ Batterham et al rately assessing body composition in HIV-positive people with lipodystrophy (Schwenk et al, 1999) is also questioned particularly in those with visceral adiposity. The impedance of the body is primarily determined by the limbs; the relatively short length and large diameter of the trunk in subjects with lipodystrophy reporting visceral adiposity may result in an underestimation of the total body water and hence the fat-free mass (Deurenberg, 1996) . Published literature investigating REE in people with HIV is primarily cross-sectional. It is possible the discrepancies in the effect of HIV on REE reflect changes in the resting metabolic rate during the HIV disease process itself or with different patients being affected by secondary infections. This heterogeneity is supported by Sharpstone et al (1996a, b) , who found that REE was decreased in subjects with some opportunistic infections, for example protozoal diarrhoea, and increased in subjects with other sites of infection, for example Pneumocystis carnii pneumonia and Mycobaterium avium-intracellulare. It may be that REE changes during HIV disease progression and such change may contribute to weight loss in the long term. Factors such as malabsorption may also confound the previous analysis of metabolism in people with HIV, particularly prior to the introduction of HAART. Jimenez-Exposito et al (1998) showed that REE per kg of FFM (estimated using bioelectrical impedance analysis) was lower in those HIV patients with malabsorption (assessed using D-xylose and triolein breath tests) than those without malabsorption. It should be noted that HAART has been associated with improvements in intestinal permeability which would mitigate such effects (Carbonnel et al, 1998; Miao et al, 2000) . In both HIVpositive groups REE per kg of FFM was higher than healthy controls, although the results were not statistically significant. The patients in the present study did not report or display clinical features of fat or protein malabsorption however this was not formally assessed by stool analysis or biopsy. Macallan et al (1995) investigated the influence of REE on total energy expenditure in people with HIV in examining the causes of weight loss. Total energy expenditure was not abnormally high in weight-stable HIV patients. Those losing weight had a reduced total energy expenditure. Although REE was elevated by comparison to healthy controls, total energy expenditure was reduced by compensatory decreases in physical activity. The elevations in REE (adjusted for fatfree mass) were not consistent across all the subsets of HIV-positive subjects. Subjects with stage IV disease (had previously had an AIDS-defining illness) had a significantly higher adjusted REE per kg FFM than the controls. In contrast although the mean REE per kg of FFM was elevated for the HIV-positive subjects as a group in the present study, only the weight stable group had an REE per kg FFM greater than the controls in the four group analysis. The elevation in REE adjusted for FFM in the weight stable group in the present study requires further investigation. In this study the weight loss group did not have higher adjusted REE when compared with the healthy controls; it is acknowledged, however, that a larger sample size and tighter standard deviations in the control group may alter this result.
Body composition is heterogeneous in the sample population of HIV-positive men reported in the present study. Although the mean values for all the HIV-positive subjects together were not significantly different from the controls, absolute FFM was lower in the subjects with weight loss when compared with all other groups and percentage fat mass was lower in the subjects with LD when compared with controls. Consequential to FFM being the metabolically active tissue, abnormalities in the relative amount of fatfree mass are likely to affect the utility of standard prediction equations based on subjects of normal body composition. Our novel finding on the role of the fat mass which has not previously been investigated in this patient group, definitively determines its contribution to REE.
In this study we found that in a cross section of HIVpositive males standard prediction equations were unable to assess REE accurately and this is likely to be a result of the abnormalities in body composition. In addition we found that two equations previously developed in people with HIV=AIDS overestimated REE. We postulate that changes in the disease related to more effective antiretroviral therapy and the appearance of different body composition abnormalities (LD) mean previously developed equations are no longer accurate in this patient group. The majority of subjects in the present study were HAART users; it may be the case that previously developed equations give more accurate results in populations without a high HAART usage.
Although some researchers have reported that FM contributes significantly to REE (Bernstein et al, 1983; Dionne et al, 1999; Ferraro & Ravussin, 1992; Garrow & Webster, 1985; Nelson et al, 1992; Nielsen et al, 2000) , others have not found a relationship with the FM (Cunningham, 1980 (Cunningham, , 1991 Mifflin et al, 1990; Ravussin et al, 1986 ). Yet most of this research has been conducted in healthy or obese populations. It is possible the relationship between REE and body composition differs in people with HIV=AIDS and assumptions produced from control populations may not be relevant to people with HIV=AIDS.
Changes in dietary intake are known to regulate REE. Decreased intake results in a compensatory decrease in REE (Newsholme & Leech, 1988) . In order to account for the confounding effects of diet, intake was measured in this study. Dietary intake as reported was adequate in this study with a mean at 116 AE 26% of requirements estimated using the HBE and the differences between the three HIV-positive groups were not significant using ANCOVA (accounting for age, weight, height and activity level). For this reason it is unlikely that dietary intake resulted in changes in REE in the present study.
Conclusions
Although mean REE adjusted for both the FFM and FM was significantly higher in HIV-positive subjects when compared Energy requirements for HIV/AIDS men MJ Batterham et al with controls, division of the HIV subjects into subgroups showed that both the weight stable HIV-positive subjects and those with LD had significantly greater REE than the controls. The difference in the group with weight loss was not statistically significant. The aetiology of this hypermetabolism requires investigation, preferably in a longitudinal study. Heterogeneity in body composition within subgroups of HIV-infected men made standard prediction equations for estimating REE invalid in this patient group. Prediction equations taking into account the body composition are recommended for use in HIV-positive subjects.
